InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: EIT post# 60988

Thursday, 10/26/2017 1:37:03 PM

Thursday, October 26, 2017 1:37:03 PM

Post# of 140474
Insider's article (Titan is running...) is interesting but a little underinformed. They are implying Titan is pushing a few systems into hospitals as sales, although they eventually use the word preclinical. "The sales cycle on this sort of technology is pretty long, meaning the going is relatively slow..." The going isn't slow, but it might be if they were trying to sell systems. Also, they point out the Da Vinci is 20 years old... as if Intuitive hasn't done anything at all to update the technology in two decades. And they want surgeon feedback, but fail to mention the feedback we got out of Nicholson. With a little more research and some better insight, this could have been a really good article for us!

As for the TRXC article, that was REALLY interesting! I posted recently that Senhance (as ALF-X) was CE marked December 2011 and marketed starting January 2012; I knew about how dismal sales had been but I thought they might have picked up a couple additional sites in Europe by now - I guess not! And yes, If our BOD starts selling large numbers of shares, I would be greatly concerned. But ours is buying while TRXC's is selling. Anyone want to guess how long until TITXF PPS is higher than TRXC's? I'm thinking by February...